The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance | Zendy

Brian Rice | Zendy; Andrew Boulle | Zendy; Sandra Schwarcz | Zendy; Amir Shroufi | Zendy; George W. Rutherford | Zendy; James Hargreaves | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

Author(s) -

Brian Rice,

Andrew Boulle,

Sandra Schwarcz,

Amir Shroufi,

George W. Rutherford,

James Hargreaves

Publication year - 2018

Publication title -

jmir public health and surveillance

Language(s) - English

Resource type - Journals

ISSN - 2369-2960

DOI - 10.2196/11136

Subject(s) - human immunodeficiency virus (hiv) , antiretroviral therapy , medicine , epidemiology , epidemiological surveillance , viral load , intensive care medicine , immunology , pathology

The move toward universal provision of antiretroviral therapy and the expansion of HIV viral load monitoring call into question the ongoing value of CD4 cell count testing and monitoring. We highlight the role CD4 monitoring continues to have in guiding clinical decisions and measuring and evaluating the epidemiology of HIV. To end the HIV/AIDS epidemic, we require strategic information, which includes CD4 cell counts, to make informed clinical decisions and effectively monitor key surveillance indicators.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research